Home / Inspections / 1112679

FDA Inspection 1112679 — Theravant Corporation

Theravant Corporation — FEI 3008516354

The FDA completed an inspection of Theravant Corporation on November 20, 2019 in Livermore, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 20, 2019
Fiscal Year
2020
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Livermore, CA (United States)

Facility

Other inspections at this facility

  • 983047 (NAI Mon Mar 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 865870 (NAI Thu Feb 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources